Dow Jones – Glenmark Pharma secures its place in Dow Jones Sustainability Rising Markets Index

Glenmark Prescription drugs has been listed within the Dow Jones Sustainability Index (DJSI), beneath the class of rising markets for the third consecutive yr in a row.

DJSI is without doubt one of the world’s most revered and extensively accepted sustainability benchmarks globally with solely the highest ranked firms by way of Company Sustainability inside every business featured within the index.

The DJSI analyses firms on their company financial, environmental and social efficiency, to evaluate points akin to however not restricted to company governance, threat administration, environmental coverage and administration programs, provide chain administration, occupational well being and security, labor practices, innovation and cyber safety amongst others. Inclusion on this record is taken into account extremely prestigious by world traders, monetary analysts and different stakeholders and serves as a benchmark for traders who combine sustainability issues into their portfolios.

“DJSI is universally acknowledged as one of the most respected and accepted sustainability benchmarks and so it is a matter of great pride for us to be included in the list for the third consecutive year. We recognise that sustainability is a continual process that encompasses our operations, stakeholders, communities and the planet at large. Our inclusion in this list underscores our consistent performance across all sustainability indicators,” mentioned Glenn Saldanha, Chairman and Managing Director, Glenmark Prescription drugs.

Over 800 firms throughout sectors from the rising markets have been assessed, out of which 100 made it to the distinguished index this yr together with 11 from India. Glenmark is without doubt one of the solely two firms from the Indian Pharmaceutical sector to be featured within the DJSI Rising Markets 2020. Glenmark is ranked 13th amongst world pharmaceutical firms.